Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition used for preventing primary tumor metastasis after exairesis

A primary tumor, surgical resection technology, used in antitumor drugs, drug combinations, active ingredients of phosphorus compounds, etc.

Inactive Publication Date: 2014-04-09
贾力
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Surgical resection is the preferred treatment option for primary tumors, which do not require "anticancer drugs"; when drugs are needed to prevent metastatic spread of tumors after surgery, there are currently no such drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0025] Tablet preparation of combination medicine: Active ingredients such as oleanane-type ginsenoside Rg3 (100mg), periostin (10mg), metapristone (2mg), aspirin (25mg), and lysine (10mg) will be prepared Mixed with microcrystalline cellulose (100 mg), and modified corn starch (100 mg), prepared into granules and sieved. The sieved granules were mixed with modified corn starch (100 mg) and magnesium stearate (1 mg), and the mixture was compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition used for comprehensive prevention of primary tumor metastasis after exairesis. The pharmaceutical composition is composed of five kinds of drugs, which are capable of increasing body internal tumor immune functions, inhibiting marrow internal circulation tumor cell activity, inhibiting adhesion and implantation of circulating tumor cells in blood onto tunica elastica interna, preventing aggregation of circulating tumor cells in blood vessels, and strengthening tissue matrix structures respectively. Each of the five drug is capable of controlling a different point related to tumor metastasis. Optimized combination of the five drugs is capable of preventing tumor cells from metastasis after exairesis effectively and safely.

Description

technical field [0001] The present invention relates to an optimized combination of five types of drugs in order to comprehensively and safely prevent or adjuvantly treat tumor re-metastasis (or recurrence) in mammalian patients after surgical resection of the primary tumor. Background technique [0002] The defect of existing technology and the beneficial effect of the present invention: over the past 50 years, the death rate of other major diseases (heart disease etc.) has declined substantially (>60%), but cancer death rate has only reduced about 5%, wherein most Most died of tumor metastasis. The death caused by tumor metastasis is currently a global economic, social, and technological problem that needs to be solved urgently. The research and development of traditional mainstream "anticancer drugs" followed a slow and stupid route of "fighting cancer after cancer metastasis", with little effect. The current "effective" chemotherapy drugs can not effectively control...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/06A61K38/17A61P35/04
CPCA61K9/2059A61K31/167A61K31/198A61K31/40A61K31/405A61K31/415A61K31/567A61K31/616A61K31/663A61K31/704A61K33/42A61K36/074A61K36/21A61K36/75A61K38/17A61K45/06A61K2300/00
Inventor 贾力
Owner 贾力
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com